Saudi Healthtech Madeed Raises $925K for Preventive Care

Saudi startup Madeed raises $925K to build an AI-driven preventive healthcare platform, signaling rising investor interest in MENA healthtech. 

The round was backed by SEEDRA Ventures, Unity Investment Partners, and Seen Growth, following an earlier $400,000 investment led by Vision Ventures and a group of Saudi investors.

Also Read: e& Capital Backs MagicCube in $10M Deal to Boost GCC Fintech Security 

Founded by Dr Adam Bataineh, Madeed is developing a preventive health platform that utilizes laboratory testing and artificial intelligence to identify early indicators of disease risk before symptoms appear. The company focuses on integrating diagnostics with data-driven insights to support long-term health management.

The new funding will be used to develop the platform’s products further and expand partnerships with clinical and laboratory providers, with an initial focus on scaling operations in Saudi Arabia.

Madeed’s approach reflects a broader shift in healthcare models across the MENA region, where systems have traditionally been centred on treatment rather than early intervention. Startups in diagnostics, wellness, and AI-driven healthcare are increasingly attracting early-stage investment, particularly in Saudi Arabia, where healthcare transformation remains a national priority.

The company has completed initial operational testing and onboarded early users, with its next phase focused on broader rollout and adoption. Industry observers note that the success of such platforms will depend on user uptake and the ability to integrate with existing healthcare infrastructure.

Why Madeed Funding Matters to MENA

The funding secured by Madeed highlights a growing shift across the MENA region toward preventive and data-driven healthcare models. 

In markets like Saudi Arabia, where healthcare systems have traditionally focused on treatment, platforms that emphasize early detection and personalized health management could help reduce long-term costs and improve outcomes. 

The development also reflects increasing investor interest in healthtech, particularly in areas such as diagnostics and AI, as the region looks to modernize healthcare infrastructure and support more sustainable, technology-enabled care delivery.